132 related articles for article (PubMed ID: 7013666)
1. Amyloidosis.
Gorevic PD; Franklin EC
Annu Rev Med; 1981; 32():261-71. PubMed ID: 7013666
[No Abstract] [Full Text] [Related]
2. [Amyloidosis in patients with rheumatoid arthritis].
Bluszcz-Roznowska A; Kucharz EJ
Przegl Lek; 2005; 62(12):1532-7. PubMed ID: 16786790
[TBL] [Abstract][Full Text] [Related]
3. [Secondary amyloidosis in patients with rheumatoid arthritis].
Yasuda M
Nihon Rinsho; 2005 May; 63 Suppl 5():386-90. PubMed ID: 15954381
[No Abstract] [Full Text] [Related]
4. [Secondary amyloidosis associated with rheumatoid arthritis (RA)].
Koseki Y; Goto M
Nihon Rinsho; 2005 Jan; 63 Suppl 1():278-82. PubMed ID: 15799361
[No Abstract] [Full Text] [Related]
5. [Amyloidosis: protein thesaurismosis].
Tena X; Olivé A
Med Clin (Barc); 1994 Sep; 103(9):348-56. PubMed ID: 7967897
[No Abstract] [Full Text] [Related]
6. [Secondary amyloidosis in patients with rheumatoid arthritis(RA)].
Inada S
Nihon Rinsho; 2002 Dec; 60(12):2417-22. PubMed ID: 12510371
[TBL] [Abstract][Full Text] [Related]
7. [Systemic secondary AA amyloidosis].
Cadiñanos J; Costa R; Trujillo D; Real de Asúa D
Med Clin (Barc); 2015 Apr; 144(7):324-30. PubMed ID: 25023854
[No Abstract] [Full Text] [Related]
8. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
Westermark GT; Westermark P
FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options in systemic AL amyloidosis.
van Gameren II; Lokhorst H; Hazenberg BP; Vellenga E
Neth J Med; 2004 Apr; 62(4):106-13. PubMed ID: 15255079
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
Maury CP; Wegelius O
Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
[TBL] [Abstract][Full Text] [Related]
11. The cutaneous amyloidoses. Pathogenesis and therapy.
Breathnach SM
Arch Dermatol; 1985 Apr; 121(4):470-5. PubMed ID: 3883907
[No Abstract] [Full Text] [Related]
12. Amyloidosis: a clinical overview.
Hazenberg BP
Rheum Dis Clin North Am; 2013 May; 39(2):323-45. PubMed ID: 23597967
[TBL] [Abstract][Full Text] [Related]
13. [Current theories on the pathogenesis of amyloidosis].
Kordecki H
Wiad Lek; 1982 Oct; 35(18):1171-6. PubMed ID: 6817524
[No Abstract] [Full Text] [Related]
14. [Secondary (AA) amyloidosis].
Komatsuda A; Miura AB
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):488-91. PubMed ID: 9851197
[No Abstract] [Full Text] [Related]
15. [Amyloidosis].
Moszczyński P
Pieleg Polozna; 1984; (10):16-7. PubMed ID: 6570234
[No Abstract] [Full Text] [Related]
16. Systemic amyloidosis: a clinical survey of 144 cases.
Janssen S; Van Rijswijk MH; Meijer S; Ruinen L; Van der Hem GK
Neth J Med; 1986; 29(11):376-85. PubMed ID: 3808140
[No Abstract] [Full Text] [Related]
17. [Therapy possibilities in AA amyloidosis in long-term Crohn disease].
Knebel U; Arnold JC; Schilling D; Nüsse T; Riemann JF
Dtsch Med Wochenschr; 2001 Mar; 126(10):279-82. PubMed ID: 11285764
[No Abstract] [Full Text] [Related]
18. Amyloid and inflammation.
Gorevic PD
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16291-2. PubMed ID: 24067661
[No Abstract] [Full Text] [Related]
19. A case of primary systemic amyloidosis with AA protein.
Okada K; Takahashi S; Horiuchi K; Nagura Y; Hatano M
Nihon Jinzo Gakkai Shi; 1991 May; 33(5):529-31. PubMed ID: 1895552
[TBL] [Abstract][Full Text] [Related]
20. Amyloid proteins, precursors, mediator, and enhancer.
Cohen AS; Shirahama T; Sipe JD; Skinner M
Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
